Directorate announcement

RNS Number : 2372Z
Spire Healthcare Group PLC
17 September 2020
 

Spire Healthcare Group plc

 

("Spire Healthcare", "the Company" or "the Group")

 

Directorate announcement

 

 

Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital group, today announces Garry Watts has informed the Board of his desire to retire after nearly ten years as Chairman of the Group at its next AGM, or sooner if a replacement is in place.

 

A process to find a new non-executive Chairman is underway and further updates will be provided in due course.

 

Garry Watts commented: "It is with sadness that I will be retiring from the Board after ten years, during which time the business has evolved significantly to become one of the UK's leading independent hospital groups, delivering the highest levels of patient care. I am confident that Spire has a bright future ahead led by its strong management team and Board."

 

Martin Angle, Deputy Chairman and Senior Independent Director, commented: "On behalf of the Board, I would like to thank Garry for his exceptional stewardship of Spire Healthcare and significant contribution to the Company over the course of the past ten years. His expertise and guidance have proved instrumental in helping the business grow to what it has become today, and we wish him an extremely enjoyable and well-deserved retirement."

 

 

For further information please contact:

 

Spire Healthcare 

Cora McCallum, Head of Investor Relations

 

+44 (0)7967 109 731

Instinctif Partners 

Damian Reece

Guy Scarborough

Jeremy Durrant

 

+44 (0)7931 598 593

+44 (0)7917 178 920

+44 (0)7792 918 648


Registered Office and Head Office:

 

Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and 8 clinics across England, Wales and Scotland.

 

Spire Healthcare delivered tailored, personalised care to approximately 810,000 in-patients and daycase patients in 2019, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. The Group's well located and scalable hospitals have delivered successful and award winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. Spire treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFLFATIRLII
UK 100

Latest directors dealings